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Introduction. Lung hamartomas are the most common benign tumors of the lung. Typically, they are located in the peripheral
lung, while an endobronchial localisation is rare. Case Presentation. We present a case with the rare diagnosis of an endobronchial
hamartoma as incidental ﬁnding in a 69-year-old male, caucasian patient with atrial ﬁbrillation. At ﬁrst admission, the patient’s
exertional dyspnea was caused by atrial ﬁbrillation. Relapse of exertional dyspnea in the absence of arrhythmia was due to
postobstructive pneumonia caused by an endobronchial hamartoma. Conclusion. Endobronchial tumors such as endobronchial
lipoma or hamartoma should be considered as potential causes of exertional dyspnea and thus as diﬀerential diagnosis of atrial
ﬁbrillation. Although endobronchial hamartomas are benign, resection is recommended to prevent postobstructive lung damage.
1.Introduction
Hamartoma is the most common benign pulmonary tumor.
Endobronchial lipomatous hamartoma is a rare benign tu-
mor of the endobronchial tree. It is often diagnosed late
whenpostobstructivecomplications,suchaspneumoniaand
bronchiectasis, and irreversible pulmonary damage have al-
ready occurred.
2. Case Presentation
A 69-year-old patient was admitted to the hospital with exer-
tional dyspnea and shortness of breath. He denied cough or
hemoptysis and negated questions for nightsweats, fever, or
weight loss. The patient had never smoked.
Routine laboratory workup was normal. Physical exam-
ination revealed slightly diminished breath sounds in the
right basal lung ﬁeld. The chest scan showed a prominent
right hilum, but no pleural eﬀusion or pulmonary inﬁltrates
were noted. Pericardial eﬀusion was ruled out by cardiac
ultrasound.
Electrocardiogram showed persistent atrial ﬁbrillation
(AF). Previously, the patient had undergone various thera-
pies for AF including recurrent electric cardioversions and
catheter ablation of the pulmonary veins. Thus, dyspnea was
initially thought to be related to AF, and reisolation of the
pulmonary veins was performed successfully. To screen for
coronary artery disease prior to the administration of a class
I antiarrhythmic drug as relapse prophylaxis, a noncontrast-
enhanced,ECG-gatedMultidetectorCT(MDCT)scanofthe
heart was performed. Presence of relevant coronary calcium
w a se x c l u d e d ,b u tM D C Tr e v e a l e dar o u n dm a s so f1 . 9c m
diameterwithfatequivalentCTdensityvaluesintherightin-
termediate bronchus as an incidental ﬁnding (Figures 1(a)–
1(d)).Therewasnocontrastenhancementorpopcorncalcif-
ication of the tumor. Lymph nodes were not enlarged. Since
dyspnea improved after conversion into the sinus rhythm,
the patient was discharged and referred for further workup
of this ﬁnding on an outpatient basis.2 Case Reports in Medicine
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Figure 1: (a) On p.a. chest X-ray a prominent right hilum and a subtle increase in parenchymal density in the right infrahilar region
was noted, a mass could not be clearly identiﬁed, however. (b) A noncontrast-enhanced CT scan of the chest revealed a mass within the
bronchus intermedius (arrow) consisting mostly of fat with minimal inclusions of soft tissue density (Ao: Aorta ascendens; PT: pulmonary
trunk; LA: left atrium). (c) Coronal slide in inverted thin-volume-rendering-technique of a contrast-enhanced CT scan performed for
further workup demonstrated position and extent of the mass within the bronchus intermedius. (d) Virtual-bronchoscopy reconstruction
from the nonenhanced CT scan displayed the mass within the proximal bronchus intermedius. The adjacent upper lobe bronchus was not
aﬀected. (e) Endobronchial round tumorous obstruction of the intermediate bronchus with a smooth surface with subtotal obstruction of
the intermediate bronchus. (f) Recurent subtotal exclusion of the intermediate bronchus in the course of the disease and repetition of Argon
laser therapy. (g) Incipient focal metaplasia of respiratory mucosa into squamous epithelium.Case Reports in Medicine 3
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Figure 2:(a)Partofthehamartomaextendingpolyploidlyintotheendobronchiallumenwithtransitioninthemorespindle-celllike(arrow)
and osseous component (star) (HE, 25-fold magniﬁcation). (b) Further components of the hamartoma with chondroid parts (B, HE, 100-
fold magniﬁcation) within a cell-reduced, partly fascilular stroma with a hemangio pericytoma-like vessel pattern.
On a follow-up visit one month later, he again com-
plainedofdyspnoeaonexertion.Thistime,AFwasruledout.
Acontrast-enhancedMDCTscanofthechestwasperformed
and revealed a beginning middle lobe pneumonia.
Flexible bronchoscopy detected a round tumorous lesion
with a smooth surface without hypervascularization subto-
tally occluding the intermediate bronchus. The intermediate
bronchus could be passed by the bioptic gripper and brush
only, but not with the bronchoscope itself (Figures 1(e)–
1(g)). Microbiological analysis of the bronchoalveolar lavage
revealed E.coli, thus therapy with amoxicillin/clavulan acid
was initiated.
Histopathological examination of the biopsies showed
benign bronchial mucosa of the intermediate bronchus with
edema, ﬁbrosis, and chronic inﬂammation. There was no
evidence for malignancy, carcinoid tumor, granulomatous
inﬂammation, or acid fast rods. In deeper layers, mature
fatty tissue could be detected marginally, suggesting a lipoma
or lipomatous hamartoma. The endobronchial tumor was
removed to 95% by loop excision and laser therapy (9000J)
in a second rigid bronchoscopy. Argon laser therapy was
repeated once due to extensive mucous retention and sub-
total occlusion of the intermediate bronchus. The patient
was discharged from the hospital in good performance status
one week later. Initially, follow-up bronchoscopies were per-
formed monthly. Due to progredient granulation and occlu-
sion of the middle lobe, endoluminal laser therapy was re-
peated twice (5500J), two and three months later.
Recurrent obstructions of the middle lobe combined
with incipient focal metaplasia of respiratory mucosa into
squamous epithelium indicated surgical sleeve resection of
the middle lobe, which was successfully performed six
months after ﬁrst diagnosis. Serum tumor markers CEA,
CYFRA 21-1, NSE, and SCC were normal, Pro GRP
(40pg/mL) was slightly elevated.
Histological examination of the resected tissue showed a
mature benign tissue consisting of diﬀerent components in
accordance with the diagnosis of an endobronchial hamar-
toma (Figure 2). After surgical resection, the patient’s dysp-
nea and constitution improved rapidly.
3. Discussion
Lung hamartomas are the most common benign pulmonary
tumors (incidence between 0.025% and 0.32% [1]), mostly
localized in the peripheral lung. In one large retrospective
observational case study, the relative frequency of endo-
bronchial hamartomas was found to be rare since they ac-
counted for only 1.4% of pulmonary hamartomas [2]. In
contrast, older studies have reported a considerably higher
frequency of endobronchial hamartomas, ranging between
8–20% of all pulmonary hamartomas [3–5].
Endobronchial hamartomas originate from the bronchus
and may contain components of mature cartilage, muscle,
fat, ﬁbrous tissue, and epithelial components. Typically, en-
dobronchial hamartoma contains more fat than parenchy-
mal hamartoma [6].
Middle/old-aged (5th–7th decade) men are predomi-
nantly aﬀected with a male:female ratio of 3–5:1 [7]. The
majority (>80%) of patients with hamartomas are smokers
[2].
Although endobronchial hamartoma is a benign tumor,
early diagnosis and therapy are necessary to prevent posto-
bstructive lung damage and preserve distal lung function.
Clinical symptoms often occur late [2] in dependency on the
degree of airway obstruction and cannot be distinguished
from other causes of endoluminal obstruction. Common
symptoms include cough, wheezing, and intermittent short-
ness of breath leading to misdiagnoses of asthma or chronic
obstructive pulmonary disease [8, 9]. Hemoptysis can occur
inpatientswithlunghamartomas,whileendobronchiallipo-
mas are not vascularized and thus are not typically associ-
ated with hemoptysis (unless as a symptom of a postobstruc-
tive infection).
Sensitivity of chest X-ray in the diagnosis of endobron-
chial tumors is low (66%). Findings are often nonspeciﬁc
and related to postobstructive changes such as pleural eﬀu-
sions and atelectasis in symptomatic patients and enlarged
hila, parenchymatous consolidation, and bronchiectasis in
asymptomatic patients. MDCT and MRI can narrow diﬀer-
ential diagnoses to endobronchial lipomatous hamartoma or4 Case Reports in Medicine
endobronchial lipoma if the tumor contains fatty tissue. CT
then typically shows a fatty lesion with a density between
70HU–140HU without contrast enhancement. Whereas en-
dobronchial lipoma shows a homogenous fat density, tissue
d e n s i tyi sm o r eh e t e r o g e n o u si nh a m a rt o m aa n dm i gh ts h o w
additional calciﬁcation in up to one third of hamartomas
[6, 10]. Similar results can be obtained by MRI [11]. Bron-
choscopy is indispensable for diﬀerentiation from maligna-
ncy and inﬂammation.
Early resection of benign endobronchial tumors may
avert signiﬁcant morbidity and prevent distal lung damage.
The method of resection (surgical versus bronchoscopic) de-
pends on operability of the patient, tumor size, and the
degree of lung damage.
Bronchoscopic resection and electrosurgery by Argon
plasma(APC)andYAGlasercanachievecompleteresolution
of symptoms with low interventional risk compared to
surgery [12]. Completely resected endobronchial hamar-
toma has a low rate of recurrence [7]. Since endobronchial
resection is often not complete due to tumor growth into
the bronchus wall, relapses can occur after endobronchial
resection. If the tumor is diagnosed late and extended irre-
versiblelungdamagehasalreadyoccurredoriftumordignity
is uncertain, a surgical approach (pneumonectomy, lobec-
tomy) is the therapy of choice. Prognosis of endobronchial
hamartoma is good. Most hamartomas grow slowly, and risk
of malignancy is low [7]. Nevertheless, cytogenetic studies
have identiﬁed chromosomal recombinations 6p21 and
14q24 supporting that hamartomas can be clonal diseases. In
single cases, endobronchial hamartoma can be transformed
into malignant sarcoma [13].
4. Conclusion
In our male, middle-aged patient the diagnosis of endo-
bronchialhamartomawasmadeincidentallybyCTscreening
for coronary calcium. Initially, the symptom of exertional
dyspnea was related to AF and improved after conversion to
sinus rhythm. On second admission due to reoccurrence of
exertional dyspnea, CT scan showed a beginning pneumonia
caused by an endobronchial tumor leading to postobstruc-
tive infection as diﬀerential diagnosis for the dyspnea.
Initial histology from bronchoscopy revealed an endo-
bronchial lipoma, whereas ﬁnal histology performed in mat-
erial from the complete surgical resection showed a hamar-
toma. Both tumors are mesenchymal tumors and since ha-
martomas may contain fatty tissue, material for ﬁrst histol-
ogy might only have included the fatty layer of the original
hamartoma. Finally, surgical resection signiﬁcantly im-
proved the physical constitution of the patient.
Taken together, endobronchial tumors such as endo-
bronchiallipomaorhamartomashouldbeconsideredasrare
diﬀerential diagnosis of exertional dyspnea that can lead to
permanent lung damage if not diagnosed and treated at an
early stage.
Our case report could teach an important lesson in
primary patient care. Recurrent patient complaints are often
attributed to a previously established diagnosis such as the
link between atrial ﬁbrillation and dyspnoea in our case
report. Nevertheless, if previous etiology can be ruled out
or can just explain in part the severity of the recurrent
symptom, it is important to consider other diﬀerential
diagnoses.
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